185 related articles for article (PubMed ID: 35313905)
1. Outcomes of proton therapy for non-small cell lung cancer in patients with interstitial pneumonia.
Hashimoto S; Iwata H; Hattori Y; Nakajima K; Nomura K; Hayashi K; Toshito T; Yamamori E; Akita K; Mizoe JE; Ogino H; Shibamoto Y
Radiat Oncol; 2022 Mar; 17(1):56. PubMed ID: 35313905
[TBL] [Abstract][Full Text] [Related]
2. Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung Cancer.
Hatayama Y; Nakamura T; Suzuki M; Azami Y; Ono T; Yabuuchi T; Hayashi Y; Kimura K; Hirose K; Wada H; Hareyama M; Kikuchi Y; Takai Y
Clin Lung Cancer; 2016 Sep; 17(5):427-432. PubMed ID: 26725851
[TBL] [Abstract][Full Text] [Related]
3. Early stage non-small cell lung cancer treated with pencil beam scanning particle therapy: retrospective analysis of early results on safety and efficacy.
Chen J; Lu JJ; Ma N; Zhao J; Chen C; Fan M; Jiang G; Mao J
Radiat Oncol; 2019 Jan; 14(1):16. PubMed ID: 30683133
[TBL] [Abstract][Full Text] [Related]
4. Proton Beam Therapy for Histologically or Clinically Diagnosed Stage I Non-Small Cell Lung Cancer (NSCLC): The First Nationwide Retrospective Study in Japan.
Ohnishi K; Nakamura N; Harada H; Tokumaru S; Wada H; Arimura T; Iwata H; Sato Y; Sekino Y; Tamamura H; Mizoe JE; Ogino T; Ishikawa H; Kikuchi Y; Okimoto T; Murayama S; Akimoto T; Sakurai H
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):82-89. PubMed ID: 31580927
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated Proton Beam Therapy for cT1-2N0M0 Non-small Cell Lung Cancer Patients With Interstitial Lung Disease.
Saito T; Ohnishi K; Ishikawa H; Nakamura M; Hoshiai S; Numajiri H; Murofushi KN; Mizumoto M; Okumura T; Sakurai H
Anticancer Res; 2021 Nov; 41(11):5635-5642. PubMed ID: 34732436
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer.
Nakajima K; Iwata H; Ogino H; Hattori Y; Hashimoto S; Toshito T; Hayashi K; Akita K; Baba F; Nakamae K; Mizoe JE; Shibamoto Y
Radiat Oncol; 2018 Oct; 13(1):199. PubMed ID: 30305125
[TBL] [Abstract][Full Text] [Related]
7. Ablation of Stage I-II Non-Small Cell Lung Cancer in Patients With Interstitial Lung Disease: A Multicenter Retrospective Study.
Fintelmann FJ; Graur A; Oueidat K; Simon J; Barnes JMH; McDermott S; Genshaft SJ; Healey TT; Suh RD; Maxwell AWP; Abtin F
AJR Am J Roentgenol; 2024 Feb; 222(2):e2330300. PubMed ID: 37966037
[No Abstract] [Full Text] [Related]
8. Multi-Institutional Prospective Study of Reirradiation with Proton Beam Radiotherapy for Locoregionally Recurrent Non-Small Cell Lung Cancer.
Chao HH; Berman AT; Simone CB; Ciunci C; Gabriel P; Lin H; Both S; Langer C; Lelionis K; Rengan R; Hahn SM; Prabhu K; Fagundes M; Hartsell W; Mick R; Plastaras JP
J Thorac Oncol; 2017 Feb; 12(2):281-292. PubMed ID: 27826034
[TBL] [Abstract][Full Text] [Related]
9. Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas : Ablative dose PBT for NSCLC.
Lee SU; Moon SH; Cho KH; Pyo HR; Kim JY; Kim DY; Kim TH; Suh YG; Kim YJ
Strahlenther Onkol; 2016 Sep; 192(9):649-57. PubMed ID: 27282279
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival outcomes and quality of life of image-guided proton therapy for operable stage I non-small cell lung cancer: A phase 2 study.
Nakajima K; Oguri M; Iwata H; Hattori Y; Hashimoto S; Nomura K; Hayashi K; Toshito T; Akita K; Baba F; Ogino H; Hiwatashi A
Radiother Oncol; 2024 Jul; 196():110276. PubMed ID: 38614284
[TBL] [Abstract][Full Text] [Related]
11. Carbon-ion radiotherapy for non-small cell lung cancer with interstitial lung disease: a retrospective analysis.
Nakajima M; Yamamoto N; Hayashi K; Karube M; Ebner DK; Takahashi W; Anzai M; Tsushima K; Tada Y; Tatsumi K; Miyamoto T; Tsuji H; Fujisawa T; Kamada T
Radiat Oncol; 2017 Sep; 12(1):144. PubMed ID: 28865463
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: A Retrospective, Single-Center Study of 55 Patients.
Bhandari RP; Stanford JD; Packianathan S; Duggar WN; Kanakamedala MR; Zhang X; Giri SP; Kumar PP; Harrell LM; Mangana SH; Yang C; Vijayakumar S
Oncology; 2016; 91(4):194-204. PubMed ID: 27427761
[TBL] [Abstract][Full Text] [Related]
13. Image-guided hypofractionated double-scattering proton therapy in the management of centrally-located early-stage non-small cell lung cancer.
Kharod SM; Nichols RC; Henderson RH; Morris CG; Pham DC; Seeram VK; Jones LM; Antonio-Miranda M; Huh S; Li Z; Hoppe BS
Acta Oncol; 2020 Oct; 59(10):1164-1170. PubMed ID: 32394776
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes of passive scattering proton beam therapy for stage I non-small cell lung cancer.
Bayasgalan U; Moon SH; Jeong JH; Kim TH; Cho KH; Suh YG
Radiat Oncol; 2021 Aug; 16(1):155. PubMed ID: 34407855
[TBL] [Abstract][Full Text] [Related]
15. Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer.
Chang JY; Komaki R; Lu C; Wen HY; Allen PK; Tsao A; Gillin M; Mohan R; Cox JD
Cancer; 2011 Oct; 117(20):4707-13. PubMed ID: 21437893
[TBL] [Abstract][Full Text] [Related]
16. Helical tomotherapy for solitary lung tumor: feasibility study and dosimetric evaluation of treatment plans.
Tomita N; Kodaira T; Matsuo M; Furutani K; Tachibana H; Daimon T; Shimizu H
Technol Cancer Res Treat; 2010 Aug; 9(4):407-15. PubMed ID: 20626206
[TBL] [Abstract][Full Text] [Related]
17. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study.
Hata M; Tokuuye K; Kagei K; Sugahara S; Nakayama H; Fukumitsu N; Hashimoto T; Mizumoto M; Ohara K; Akine Y
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):786-93. PubMed ID: 17379439
[TBL] [Abstract][Full Text] [Related]
18. High-dose proton beam therapy for stage I non-small cell lung cancer: Clinical outcomes and prognostic factors.
Makita C; Nakamura T; Takada A; Takayama K; Suzuki M; Azami Y; Kato T; Tsukiyama I; Hareyama M; Kikuchi Y; Daimon T; Hata M; Inoue T; Fuwa N
Acta Oncol; 2015 Mar; 54(3):307-14. PubMed ID: 25291076
[TBL] [Abstract][Full Text] [Related]
19. Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer.
Ueki N; Matsuo Y; Togashi Y; Kubo T; Shibuya K; Iizuka Y; Mizowaki T; Togashi K; Mishima M; Hiraoka M
J Thorac Oncol; 2015 Jan; 10(1):116-25. PubMed ID: 25376512
[TBL] [Abstract][Full Text] [Related]
20. Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience.
Jiang ZQ; Yang K; Komaki R; Wei X; Tucker SL; Zhuang Y; Martel MK; Vedam S; Balter P; Zhu G; Gomez D; Lu C; Mohan R; Cox JD; Liao Z
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):332-9. PubMed ID: 22079735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]